Mukka Proteins Ltd Falls to 52-Week Low Amidst Continued Downtrend

Stock Price Movement and Market Context

On 7 Jan 2026, Mukka Proteins Ltd’s share price touched Rs.23.59, its lowest level in the past year and an all-time low. This represents a notable fall from its 52-week high of Rs.41, indicating a depreciation of approximately 42.5% over the period. The stock has been declining for four consecutive sessions, delivering a cumulative return of -1.91% during this span. Today’s performance saw the stock underperform its FMCG sector by 1.98%, further emphasising the pressure on the share price.

The broader market environment showed mixed signals. The Nifty index closed marginally lower at 26,140.75, down 0.14% or 37.95 points, yet remained close to its 52-week high, just 0.89% shy of 26,373.20. The Nifty Midcap 100 index gained 0.45%, indicating mid-cap stocks were leading the market rally. Despite this, Mukka Proteins Ltd’s stock lagged behind, trading below all key moving averages – 5-day, 20-day, 50-day, 100-day, and 200-day – signalling a bearish technical setup.

Financial Performance and Profitability Concerns

The company’s financial indicators reveal several areas of concern. Mukka Proteins Ltd has reported negative results for seven consecutive quarters, with the latest quarter showing a Profit Before Tax (PBT) excluding other income of Rs.3.28 crores, down 67.9% compared to the previous four-quarter average. Similarly, Profit After Tax (PAT) for the quarter stood at Rs.5.88 crores, a decline of 45.9% relative to the prior four-quarter average. Interest expenses have reached a peak of Rs.12.82 crores, reflecting elevated borrowing costs.

Return on Capital Employed (ROCE) remains subdued at 9.16%, indicating limited efficiency in generating profits from the capital invested. This low profitability metric is compounded by a high Debt to EBITDA ratio of 5.26 times, suggesting challenges in servicing debt obligations. Net sales growth over the past five years has averaged 8.60% annually, which is modest and may not be sufficient to support robust long-term expansion.

Institutional Participation and Market Sentiment

Institutional investors have reduced their holdings by 0.6% over the previous quarter, now collectively owning 3.36% of the company’s shares. This decline in institutional stake may reflect a reassessment of the company’s fundamentals by investors with greater analytical resources. The stock’s Mojo Score stands at 37.0, with a current Mojo Grade of Sell, upgraded from a previous Strong Sell rating on 14 Nov 2025. The Market Capitalisation Grade is 4, indicating a relatively small market cap within its peer group.

Over the last year, Mukka Proteins Ltd has delivered a total return of -39.20%, significantly underperforming the Sensex, which gained 8.65% over the same period. The stock has also lagged behind the BSE500 index across multiple time frames, including one year, three years, and three months, underscoring persistent underperformance.

Valuation and Growth Metrics

Despite the challenges, the company exhibits some positive attributes. Operating profit has grown at an annual rate of 50.86%, suggesting pockets of operational improvement. The stock trades at an attractive valuation with an Enterprise Value to Capital Employed ratio of 1.3, which is lower than the average historical valuations of its peers. This discount may reflect market caution given the company’s recent financial results and debt profile.

However, profit levels have declined by 34% over the past year, aligning with the downward trend in share price. The combination of low ROCE, high leverage, and subdued sales growth continues to weigh on the company’s overall financial health.

Summary of Key Metrics

Mukka Proteins Ltd’s current share price of Rs.23.59 is well below all major moving averages, reflecting a bearish trend. The company’s financial performance has been marked by declining profits, elevated interest costs, and a high debt burden. While operating profit growth remains robust, overall returns and sales growth have been modest. Institutional investors have reduced their exposure, and the stock’s Mojo Grade remains in the Sell category despite a recent upgrade from Strong Sell.

In comparison, the broader market and mid-cap indices have shown resilience, with the Nifty trading near its 52-week high and mid-cap stocks leading gains. Mukka Proteins Ltd’s underperformance relative to these benchmarks highlights the challenges it faces within the FMCG sector.

Conclusion

The stock’s fall to a 52-week low of Rs.23.59 underscores ongoing concerns regarding profitability, leverage, and growth prospects. While some operational metrics show improvement, the overall financial profile and market performance remain subdued. The company’s valuation reflects these factors, trading at a discount to peers. Investors and market participants continue to monitor these developments amid a broader market environment that has been more favourable to mid-cap and FMCG stocks generally.

Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →